Greenleaf Trust Trims Stock Holdings in Agilent Technologies, Inc. (NYSE:A)

Greenleaf Trust decreased its stake in Agilent Technologies, Inc. (NYSE:AGet Rating) by 4.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,319 shares of the medical research company’s stock after selling 379 shares during the quarter. Greenleaf Trust’s holdings in Agilent Technologies were worth $869,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wellington Management Group LLP grew its position in shares of Agilent Technologies by 18.5% during the first quarter. Wellington Management Group LLP now owns 10,826,141 shares of the medical research company’s stock worth $1,432,622,000 after purchasing an additional 1,691,006 shares in the last quarter. Principal Financial Group Inc. grew its position in shares of Agilent Technologies by 62.4% during the second quarter. Principal Financial Group Inc. now owns 3,115,931 shares of the medical research company’s stock worth $370,078,000 after purchasing an additional 1,197,836 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Agilent Technologies by 67.6% during the first quarter. Goldman Sachs Group Inc. now owns 2,336,607 shares of the medical research company’s stock worth $309,203,000 after purchasing an additional 942,651 shares in the last quarter. Renaissance Technologies LLC grew its position in shares of Agilent Technologies by 196.4% during the first quarter. Renaissance Technologies LLC now owns 1,242,600 shares of the medical research company’s stock worth $164,433,000 after purchasing an additional 823,300 shares in the last quarter. Finally, BlackRock Inc. grew its position in shares of Agilent Technologies by 2.5% during the first quarter. BlackRock Inc. now owns 30,082,335 shares of the medical research company’s stock worth $3,980,792,000 after purchasing an additional 730,116 shares in the last quarter.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 6,775 shares of the firm’s stock in a transaction on Wednesday, October 19th. The stock was sold at an average price of $130.11, for a total transaction of $881,495.25. Following the transaction, the chief executive officer now directly owns 191,358 shares in the company, valued at approximately $24,897,589.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Agilent Technologies news, CEO Michael R. Mcmullen sold 6,775 shares of the firm’s stock in a transaction on Wednesday, October 19th. The stock was sold at an average price of $130.11, for a total transaction of $881,495.25. Following the transaction, the chief executive officer now directly owns 191,358 shares in the company, valued at approximately $24,897,589.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Padraig Mcdonnell sold 2,103 shares of the firm’s stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now owns 13,217 shares in the company, valued at $1,624,237.13. The disclosure for this sale can be found here. Over the last three months, insiders have sold 174,326 shares of company stock worth $26,474,537.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on A shares. KeyCorp increased their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Tuesday. Robert W. Baird increased their price target on Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday. Jefferies Financial Group increased their price target on Agilent Technologies from $158.00 to $168.00 in a research note on Tuesday. Wells Fargo & Company increased their price target on Agilent Technologies from $135.00 to $150.00 in a research note on Tuesday. Finally, Citigroup increased their price target on Agilent Technologies from $145.00 to $150.00 and gave the company a “neutral” rating in a research note on Tuesday. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $157.00.

Agilent Technologies Trading Down 1.0 %

Shares of NYSE A opened at $155.35 on Thursday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.41 and a current ratio of 2.03. The business’s 50 day moving average price is $133.55 and its 200-day moving average price is $128.29. Agilent Technologies, Inc. has a fifty-two week low of $112.52 and a fifty-two week high of $162.62. The company has a market cap of $45.99 billion, a price-to-earnings ratio of 37.25, a PEG ratio of 2.78 and a beta of 1.06.

Agilent Technologies (NYSE:AGet Rating) last issued its quarterly earnings results on Monday, November 21st. The medical research company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.39 by $0.14. Agilent Technologies had a return on equity of 30.31% and a net margin of 18.31%. The firm had revenue of $1.85 billion for the quarter, compared to the consensus estimate of $1.76 billion. During the same period in the prior year, the business posted $1.21 earnings per share. The company’s revenue for the quarter was up 11.4% on a year-over-year basis. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.64 earnings per share for the current year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be issued a $0.225 dividend. This represents a $0.90 annualized dividend and a dividend yield of 0.58%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date of this dividend is Friday, December 30th. Agilent Technologies’s dividend payout ratio is presently 20.14%.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Featured Stories

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:AGet Rating).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.